Search research articles
Contact Us
Filters
Showing results (31-40 of 121) with videos related to
Page
of 13
Sort By:
Arthritis and Rheumatism
|
April 29, 2008
The shared epitope hypothesis in rheumatoid arthritis: evaluation of alternative classification criteria in a large UK Caucasian cohort
Ann W Morgan, Lubna Haroon-Rashid, Stephen G Martin, et al.
The Journal of Investigative Dermatology
|
January 19, 2005
The effect of sun exposure in determining nevus density in UK adolescent twins
Rachel C Wachsmuth, Faye Turner, Jennifer H Barrett, et al.
The Journal of Investigative Dermatology
|
March 9, 2007
Sun-protective behaviors in families at increased risk of melanoma
Julia A Newton Bishop, Tamara Taylor, Henry W W Potts, et al.
International Journal of Cancer
|
September 8, 2004
Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer
Faye Turner, Gillian Smith, Christoph Sachse, et al.
International Journal of Cancer
|
August 9, 2011
Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom
Faye Elliott, Mariano Suppa, May Chan, et al.
The Journal of Investigative Dermatology. Symposium Proceedings
|
April 16, 2004
A quality-of-life study in high-risk (thickness > = or 2 mm) cutaneous melanoma patients in a randomized trial of 1-cm versus 3-cm surgical excision margins
Julia A Newton-Bishop, Clarissa Nolan, Faye Turner, et al.
Carcinogenesis
|
November 7, 2002
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer
Christoph Sachse, Gillian Smith, Murray J V Wilkie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2009
KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial
Susan D Richman, Matthew T Seymour, Philip Chambers, et al.
Proteomics. Clinical Applications
|
August 12, 2011
A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal disease
Douglas Thompson, Willem Develter, David A Cairns, et al.
JAMA Oncology
|
February 13, 2016
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer
Jenny F Seligmann, Faye Elliott, Susan D Richman, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 121) with videos related to
Sort By:
Page
of 13
Arthritis and Rheumatism
|
April 29, 2008
The shared epitope hypothesis in rheumatoid arthritis: evaluation of alternative classification criteria in a large UK Caucasian cohort
Ann W Morgan, Lubna Haroon-Rashid, Stephen G Martin, et al.
The Journal of Investigative Dermatology
|
January 19, 2005
The effect of sun exposure in determining nevus density in UK adolescent twins
Rachel C Wachsmuth, Faye Turner, Jennifer H Barrett, et al.
The Journal of Investigative Dermatology
|
March 9, 2007
Sun-protective behaviors in families at increased risk of melanoma
Julia A Newton Bishop, Tamara Taylor, Henry W W Potts, et al.
International Journal of Cancer
|
September 8, 2004
Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer
Faye Turner, Gillian Smith, Christoph Sachse, et al.
International Journal of Cancer
|
August 9, 2011
Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom
Faye Elliott, Mariano Suppa, May Chan, et al.
The Journal of Investigative Dermatology. Symposium Proceedings
|
April 16, 2004
A quality-of-life study in high-risk (thickness > = or 2 mm) cutaneous melanoma patients in a randomized trial of 1-cm versus 3-cm surgical excision margins
Julia A Newton-Bishop, Clarissa Nolan, Faye Turner, et al.
Carcinogenesis
|
November 7, 2002
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer
Christoph Sachse, Gillian Smith, Murray J V Wilkie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2009
KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial
Susan D Richman, Matthew T Seymour, Philip Chambers, et al.
Proteomics. Clinical Applications
|
August 12, 2011
A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal disease
Douglas Thompson, Willem Develter, David A Cairns, et al.
JAMA Oncology
|
February 13, 2016
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer
Jenny F Seligmann, Faye Elliott, Susan D Richman, et al.
Page
of 13